News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeneSegues, Inc. Appoints New SAB Member



10/19/2005 5:09:29 PM

GeneSegues, Inc., a biopharmaceutical company that develops nanoencapsulated therapeutics, today announced the appointment of Dr. Erkki Ruoslahti, Ph.D., M.D., to its Scientific Advisory Board (SAB). Dr. Ruoslahti holds the position of Distinguished Professor at the Burnham Institute in La Jolla, California.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES